Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD Disclosure
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 16, 2026, CN Healthy Food Tech Group Corp. (the “Company”) received a letter (the “Determination Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (the “Nasdaq”) stating that, based on its review of the Company’s public filings with the S…
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 3.01Item 3.01 - Notice of Delisting
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
On July 16, 2026, CN Healthy Food Tech Group Corp.
(the “Company”) received a letter (the “Determination Letter”) from the Listing Qualifications Staff (the “Staff”)
of The Nasdaq Stock Market LLC (the “Nasdaq”) stating that, based on its review of the Company’s public filings with
the SEC and other available information, the Staff has determined to delist the Company’s common stock, par value $0.0001 per share
(the “Common Stock”), and warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
per share (the “Warrant,” together with the Common Stock, the “Listed Securities”). The Staff’s determination
is based on (i) Nasdaq’s discretionary authority under Nasdaq Listing Rule 5101 and IM-5101-1 (together, “Rule 5101”),
and (ii) the Company’s alleged violation of Nasdaq Listing Rules 5205(e) and 5250(a)(1).
The Company intends to timely request an appeal
of the Staff’s determination by the deadline of July 23, 2026. A timely hearing request would stay any suspension of the Listed
Securities pending the Panel’s decision, although the trading halt currently in effect would remain in place notwithstanding any
appeal. There can be no assurance that the Company will be successful in any such appeal, or that its Listed Securities will resume trading
or continue to be listed on Nasdaq. If the Panel reached a unanimous decision against the Company, the Company may face immediate delisting
of its Listed Securities from Nasdaq.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
The Company issued press release announcing its
receipt of the Determination Letter on July 21, 2026. A copy of such press release is furnished as Exhibits 99.1 to this Current Report
on Form 8-K and incorporated herein by reference.
None of the information furnished in Item 7.01
or the accompanying Exhibit 99.1 will be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), or otherwise subject to the liability of such section, nor will such information be deemed
incorporated by reference into any filing under the Securities Act or the Exchange Act, regardless of the general incorporation language
of such filing, except as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) ea029857201ex99-1.htm
EX-99.1
2
ea029857201ex99-1.htm
PRESS RELEASE DATED JULY 21, 2026
Exhibit 99.1
CN
Healthy Food Tech Group Corp. Announces Receipt of Nasdaq Determination Letter
ZHUHAI, CHINA, July 21, 2026 (GLOBE NEWSWIRE) -- CN Healthy
Food Tech Group Corp. (Nasdaq: UCFI, UCFIW) (“CN Healthy Food Tech Group Corp.” or the “Company”) announced that
the Company received a letter (the “Determination Letter”) on July 16, 2026 from the The Nasdaq Stock Market LLC (“Nasdaq”).
As set forth in the Determination Letter, the
listing qualifications staff of the Nasdaq (the “Staff”) has determined to delist the Company’s securities based on
(i) Nasdaq’s discretionary authority under Nasdaq Listing Rule 5101 and IM-5101-1 (together, “Rule 5101”), and (ii)
a violation of Nasdaq Listing Rules 5205(e) and 5250(a)(1). The Staff’s determination arises from disclosures in the Company’s
Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (“SEC”) on September 30, 2025 regarding
the status of the review process with the China Securities Regulatory Commission (the “CSRC”).
The Company plans to timely request a hearing
before a Nasdaq hearings panel prior to the July 23, 2026 deadlin…